Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795574 · ClinicalTrials.gov registry record · Phase 2
Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa
A Phase 2 study, sponsored by Florida Academic Dermatology Centers.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00795574 is a Phase 2 study that has completed, run by Florida Academic Dermatology Centers. The registered enrollment target is 38 participants.
The verdict
NCT00795574, a Phase 2 study, has completed, sponsored by Florida Academic Dermatology Centers.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
A study to assess the safety and efficacy of the IV drug infliximab for the treatment of hidradenitis suppurativa
Interventions
- DRUG Placebo Comparator
- DRUG infliximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795574
The ClinicalTrials.gov registry entry for NCT00795574 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Academic Dermatology Centers, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT00795574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795574 about?
NCT00795574 is a clinical study titled "Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa". A study to assess the safety and efficacy of the IV drug infliximab for the treatment of hidradenitis suppurativa
What is the current status of trial NCT00795574?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2005-06. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00795574?
The interventions under investigation include: Placebo Comparator (DRUG), infliximab (DRUG).
Who is sponsoring clinical trial NCT00795574?
This trial is sponsored by Florida Academic Dermatology Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.